|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13,310.00 GBX | -0.03% |
|
-1.62% | -3.61% |
| 05-07 | Fluicell nominates AstraZeneca executive to Board of Directors | FW |
| 05-07 | Nordic stocks in North America - Autoliv fell 0.6 percent | FW |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 221.36 | +22.14% | 21 | ||||||
| 1,207.34 | +23.84% | 29 | ||||||
| 252.42 | +13.44% | 24 | ||||||
| 252.23 | +24.43% | 30 | ||||||
| 360.76 | +13.34% | 17 | ||||||
| 155.05 | +6.46% | 21 | ||||||
| 129.74 | +15.53% | 27 | ||||||
| 307.34 | +4.01% | 23 | ||||||
| 353.07 | +7.29% | 30 | ||||||
| 158.36 | +18.12% | 28 | ||||||
| 29.11 | +9.95% | 27 | ||||||
| 63.32 | +12.57% | 25 | ||||||
| 549.5 | +29.29% | 28 | ||||||
| 97.1 | +31.67% | 23 | ||||||
| 20.3 | +9.23% | 20 | ||||||
| 10,136.67 | +25.22% | 15 | ||||||
| 6,036.87 | +13.69% | 15 | ||||||
| 80.38 | +49.75% | 17 | ||||||
| 48.47 | +29.5% | 19 | ||||||
| Average | 1,076.81 | +18.92% | 23 | ||||||
| Weighted average by Cap. | 690.71 | +17.62% | 25 |
- Stock Market
- Equities
- AZN Stock
- Sector AstraZeneca PLC
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition